Table 1

BCP participant demographics (n = 39)
Characteristic Frequency
Median age at diagnosis 55.5 years (range: 35 – 85)
Cancer stage at diagnosis
  Stage 1 13 (33.3%)
  Stage 2 21 (53.8%)
  Stage 3 4 (10.3%)
  Missing/unknown 1 (2.6%)
Cancer type
  Invasive ductal carcinoma 32 (82.0%)
  Other 6 (15.4%)
  Missing/unknown 1 ( 2.6%)
Surgery type
  Lumpectomy 25 (64.1%)
  Mastectomy 13 (33.3)
  Missing/unknown 1 (2.6%)
  Received axillary lymph node dissection in addition to lumpectomy or mastectomy 14 (35.9%)
Number of patients receiving radiation therapy 31 (79.5%)
Therapy
  Chemotherapy alone 8 (20.5%)
  Chemotherapy + endocrine therapy 21 (53.8%)
  Endocrine therapy alone 9 (23.1%)
  Missing/unknown 1 ( 2.6%)
Median duration of treatment
(Chemotherapy and Biologic Therapy) 156 days (range: 117–577)
Proportion of patients receiving biologic therapy 6 (15.4%)

Haq et al.

Haq et al. BMC Medical Informatics and Decision Making 2013 13:76   doi:10.1186/1472-6947-13-76

Open Data